baseclick designs next-generation adapted ingredients
Neuried, Munich Mai 25, 2023 baseclick indicates new dimensions to approach nucleic acid-based therapies, in association with the Cluster for Nucleic Acid Therapeutics Munich (CNATM) which is an innovative network that brings research institutions and private companies for designing individualised treatment ranges together.
>Read press release (PDF)
